PayPay officer reports existing stock option grants
PayPay Corp officer Baba Hajime filed an initial Form 3 reporting existing stock option holdings, with no new purchases or sales.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PayPay Corp officer Baba Hajime filed an initial Form 3 reporting existing stock option holdings, with no new purchases or sales. The filing lists several “Stock Options (Right to Buy)” over Common Shares, including tranches for 47,400, 95,000 and 110,000 underlying shares at exercise prices of $8.1500 and $0.0060 per share.
The options expire on dates such as March 31, 2033 and April 23, 2035, and some vest in annual installments starting in 2026 and 2027. Other tranches become exercisable only upon resignation or retirement, or when PayPay’s market capitalization exceeds specified thresholds. Any Common Shares received on exercise convert into ADSs on a one-for-one basis.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Footnotes (8)
- F1. The Common Shares are represented by American Depositary Shares (ADS). The Common Shares received upon exercise of any Stock Options will be converted into ADSs on a one-for-one basis.
- F2. 19,200 of these options are fully vested with the remaining 28,200 options to vest in three equal annual installments beginning on April 1, 2026.
- F3. Reflects awards of stock options, with each option exercisable for two hundred Common Shares.
- F4. The exercise price is denominated in Japanese Yen. For purposes of calculating the dollar denominated exercise price per Common Share, the exercise price of JPY 1,300 per Common Share has been converted to U.S. Dollars at the exchange rate of JPY159.5400= US$1.00, which was the foreign exchange rate on March 13, 2026, as reported by the U.S. Federal Reserve in its weekly release on March 16, 2026. The exercise price is the actual Japanese Yen amount regardless of the exchange rate on the date of exercise.
- F5. These options vest in five equal annual installments beginning on April 26, 2027.
- F6. These options become exercisable only upon the Reporting Person's resignation or retirement from the Issuer and must be exercised within ten (10) days thereafter.
- F7. The exercise price is denominated in Japanese Yen. For purposes of calculating the dollar denominated exercise price per Common Share, the exercise price of JPY 1 per Common Share has been converted to U.S. Dollars at the exchange rate of JPY159.5400= US$1.00, which was the foreign exchange rate on March 13, 2026, as reported by the U.S. Federal Reserve in its weekly release on March 16, 2026. The exercise price is the actual Japanese Yen amount regardless of the exchange rate on the date of exercise.
- F8. These options reflect tranches that become exercisable on or after various dates between March 12, 2026 and April 1, 2028 upon the Issuer's market capitalization exceeding certain thresholds.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the PAYP Form 3 filing by Baba Hajime report?
What are the exercise prices of Baba Hajime’s PayPay (PAYP) stock options?
When do Baba Hajime’s PayPay (PAYP) stock options vest and expire?
Do any of Baba Hajime’s PAYP options depend on PayPay’s market capitalization?
AI-generated analysis. How Rhea-AI works. Not financial advice.